HUE047626T2 - Ciklin-függõ, fehérje kináz inhibitor hidroxietil-szulfonátja, annak kristályos formája és elõállítására szolgáló eljárás - Google Patents
Ciklin-függõ, fehérje kináz inhibitor hidroxietil-szulfonátja, annak kristályos formája és elõállítására szolgáló eljárásInfo
- Publication number
- HUE047626T2 HUE047626T2 HUE16746062A HUE16746062A HUE047626T2 HU E047626 T2 HUE047626 T2 HU E047626T2 HU E16746062 A HUE16746062 A HU E16746062A HU E16746062 A HUE16746062 A HU E16746062A HU E047626 T2 HUE047626 T2 HU E047626T2
- Authority
- HU
- Hungary
- Prior art keywords
- cyclin
- preparation
- crystalline form
- protein kinase
- kinase inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510056995 | 2015-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE047626T2 true HUE047626T2 (hu) | 2020-05-28 |
Family
ID=56563428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16746062A HUE047626T2 (hu) | 2015-02-03 | 2016-01-12 | Ciklin-függõ, fehérje kináz inhibitor hidroxietil-szulfonátja, annak kristályos formája és elõállítására szolgáló eljárás |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10030018B2 (hu) |
| EP (1) | EP3255046B1 (hu) |
| JP (1) | JP6920993B2 (hu) |
| CN (1) | CN106661025B (hu) |
| AU (1) | AU2016214897B9 (hu) |
| CA (1) | CA2974021A1 (hu) |
| CY (1) | CY1122514T1 (hu) |
| DK (1) | DK3255046T3 (hu) |
| ES (1) | ES2764139T3 (hu) |
| HR (1) | HRP20192286T1 (hu) |
| HU (1) | HUE047626T2 (hu) |
| LT (1) | LT3255046T (hu) |
| MX (1) | MX2017009270A (hu) |
| PL (1) | PL3255046T3 (hu) |
| PT (1) | PT3255046T (hu) |
| RS (1) | RS59782B1 (hu) |
| SI (1) | SI3255046T1 (hu) |
| TW (1) | TWI706951B (hu) |
| WO (1) | WO2016124067A1 (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10449195B2 (en) | 2016-03-29 | 2019-10-22 | Shenzhen Pharmacin Co., Ltd. | Pharmaceutical formulation of palbociclib and a preparation method thereof |
| CN109384767B (zh) * | 2017-08-08 | 2020-05-05 | 江苏恒瑞医药股份有限公司 | 一种吡啶并嘧啶类衍生物的制备方法及其中间体 |
| TWI762784B (zh) * | 2018-05-23 | 2022-05-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | Cdk4/6抑制劑與egfr抑制劑聯合在製備治療腫瘤疾病的藥物中的用途 |
| CN110790748B (zh) * | 2018-08-02 | 2022-04-19 | 江苏豪森药业集团有限公司 | 细胞周期蛋白依赖性激酶抑制剂的对甲苯磺酸盐晶型及其制备方法和用途 |
| US10857146B2 (en) | 2018-08-21 | 2020-12-08 | Jiangsu Hengrui Medicine Co., Ltd. | Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitor |
| CN113395969A (zh) | 2019-01-30 | 2021-09-14 | 江苏恒瑞医药股份有限公司 | 一种含cdk4/6抑制剂的组合物与阿那曲唑联合在制备***疾病的药物中的用途 |
| TW202114670A (zh) * | 2019-09-30 | 2021-04-16 | 大陸商江蘇恒瑞醫藥股份有限公司 | 一種ezh2抑制劑與cdk4/6抑制劑聯合在製備治療腫瘤藥物中的用途 |
| CN114306245A (zh) | 2020-09-29 | 2022-04-12 | 深圳市药欣生物科技有限公司 | 无定形固体分散体的药物组合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1835951B (zh) * | 2003-07-11 | 2010-06-02 | 沃尼尔·朗伯有限责任公司 | 选择性cdk4抑制剂的羟乙基磺酸盐 |
| BRPI0716880A2 (pt) * | 2006-09-08 | 2013-10-15 | Pfizer Prod Inc | Síntese de 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas |
| CN104470921B (zh) * | 2013-05-17 | 2017-05-03 | 上海恒瑞医药有限公司 | 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用 |
-
2016
- 2016-01-12 RS RS20191639A patent/RS59782B1/sr unknown
- 2016-01-12 MX MX2017009270A patent/MX2017009270A/es unknown
- 2016-01-12 CA CA2974021A patent/CA2974021A1/en active Pending
- 2016-01-12 LT LTEP16746062.5T patent/LT3255046T/lt unknown
- 2016-01-12 SI SI201630568T patent/SI3255046T1/sl unknown
- 2016-01-12 CN CN201680001816.3A patent/CN106661025B/zh active Active
- 2016-01-12 PL PL16746062T patent/PL3255046T3/pl unknown
- 2016-01-12 WO PCT/CN2016/070636 patent/WO2016124067A1/zh active Application Filing
- 2016-01-12 JP JP2017536246A patent/JP6920993B2/ja active Active
- 2016-01-12 EP EP16746062.5A patent/EP3255046B1/en active Active
- 2016-01-12 HU HUE16746062A patent/HUE047626T2/hu unknown
- 2016-01-12 ES ES16746062T patent/ES2764139T3/es active Active
- 2016-01-12 DK DK16746062.5T patent/DK3255046T3/da active
- 2016-01-12 US US15/546,405 patent/US10030018B2/en active Active
- 2016-01-12 AU AU2016214897A patent/AU2016214897B9/en active Active
- 2016-01-12 PT PT167460625T patent/PT3255046T/pt unknown
- 2016-01-20 TW TW105101679A patent/TWI706951B/zh active
-
2018
- 2018-04-13 US US15/952,234 patent/US10160759B2/en active Active
-
2019
- 2019-12-11 CY CY20191101295T patent/CY1122514T1/el unknown
- 2019-12-19 HR HRP20192286TT patent/HRP20192286T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN106661025B (zh) | 2019-08-16 |
| US20180230147A1 (en) | 2018-08-16 |
| SI3255046T1 (sl) | 2020-02-28 |
| TW201629060A (zh) | 2016-08-16 |
| CA2974021A1 (en) | 2016-08-11 |
| US20180009804A1 (en) | 2018-01-11 |
| PT3255046T (pt) | 2020-01-06 |
| RS59782B1 (sr) | 2020-02-28 |
| LT3255046T (lt) | 2020-01-10 |
| ES2764139T3 (es) | 2020-06-02 |
| US10160759B2 (en) | 2018-12-25 |
| US10030018B2 (en) | 2018-07-24 |
| CY1122514T1 (el) | 2021-01-27 |
| HRP20192286T1 (hr) | 2020-03-20 |
| AU2016214897B2 (en) | 2020-05-21 |
| MX2017009270A (es) | 2017-10-11 |
| EP3255046A1 (en) | 2017-12-13 |
| AU2016214897A1 (en) | 2017-08-10 |
| JP6920993B2 (ja) | 2021-08-18 |
| AU2016214897B9 (en) | 2020-06-04 |
| EP3255046B1 (en) | 2019-11-27 |
| CN106661025A (zh) | 2017-05-10 |
| DK3255046T3 (da) | 2020-01-20 |
| EP3255046A4 (en) | 2018-10-10 |
| PL3255046T3 (pl) | 2020-05-18 |
| TWI706951B (zh) | 2020-10-11 |
| JP2018503634A (ja) | 2018-02-08 |
| WO2016124067A1 (zh) | 2016-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243419B (zh) | 一種btk激酶抑制劑的結晶形式及其製備方法 | |
| HUE047626T2 (hu) | Ciklin-függõ, fehérje kináz inhibitor hidroxietil-szulfonátja, annak kristályos formája és elõállítására szolgáló eljárás | |
| PL3218378T3 (pl) | Pochodne 6-amino-7-bicyklo-7-deazapuryny jako inhibitory kinaz białkowych | |
| EP3247692A4 (en) | INHIBITORS OF TRKA KINASE | |
| HK1253537A1 (zh) | 吡咯並嘧啶激酶抑制劑的藥用鹽、物理形態和組合物及其製備方法 | |
| IL250318B (en) | Protein kinase c inhibitors and methods of using them | |
| HK1258996A1 (zh) | 新型fyn激酶抑制劑的方法、組合物以及用途 | |
| PL3447051T3 (pl) | Sposób otrzymywania inhibitora kinazy tyrozynowej i jego pochodnej | |
| EP3376870A4 (en) | PROCESS FOR PREPARING KINASE INHIBITORS AND INTERMEDIATES THEREOF | |
| ZA201808014B (en) | Adenine derivatives as protein kinase inhibitors | |
| ZA201802141B (en) | Egfr kinase inhibitor and preparation method and use thereof | |
| EP3265093A4 (en) | Tricyclic kinase inhibitors of melk and methods of use | |
| ZA201808238B (en) | Certain protein kinase inhibitors | |
| PL3327012T3 (pl) | Krystaliczne postacie bilastyny i sposoby ich wytwarzania | |
| EP3193874A4 (en) | Crystalline forms of tyrosine kinase inhibitors and their salts | |
| EP3572415C0 (en) | JAK KINASE INHIBITOR, PREPARATION METHOD AND USE THEREOF | |
| IL254597A0 (en) | Crystalline form of ahu377, method for its preparation and use | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors |